ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36212
-0.23%
Bitcoin
67,794.96
0.10%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Inhibitor Therapeutics Inc (QB) (INTI)

  7. Inhibitor Therapeutics Inc (QB) (INTI) News

INTI

Inhibitor Therapeutics (QB) (INTI)

Inhibitor Therapeutics Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:INTI
DateTimeSourceHeadlineSymbolCompany
05/16/202412:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
05/16/202412:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
05/16/202412:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
05/16/202412:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
05/16/202412:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
05/13/20248:00AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:INTIInhibitor Therapeutics Inc (QB)
12/14/20235:02AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:INTIInhibitor Therapeutics Inc (QB)
10/18/20238:54AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:INTIInhibitor Therapeutics Inc (QB)
08/29/20232:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
08/29/20231:42PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:INTIInhibitor Therapeutics Inc (QB)
08/29/20231:33PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:INTIInhibitor Therapeutics Inc (QB)
08/11/20238:15AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:INTIInhibitor Therapeutics Inc (QB)
05/31/20233:31PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:INTIInhibitor Therapeutics Inc (QB)
05/23/202311:50AMEdgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:INTIInhibitor Therapeutics Inc (QB)
05/22/20232:45PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:INTIInhibitor Therapeutics Inc (QB)
05/18/20235:02AMEdgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:INTIInhibitor Therapeutics Inc (QB)
05/17/20236:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:INTIInhibitor Therapeutics Inc (QB)
05/17/20236:11PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:INTIInhibitor Therapeutics Inc (QB)
05/17/20236:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:INTIInhibitor Therapeutics Inc (QB)
05/15/20238:04AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:INTIInhibitor Therapeutics Inc (QB)
12/19/20224:01PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:INTIInhibitor Therapeutics Inc (QB)
11/14/20223:39PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:INTIInhibitor Therapeutics Inc (QB)
09/15/20224:07PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:INTIInhibitor Therapeutics Inc (QB)
05/13/20228:02AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:INTIInhibitor Therapeutics Inc (QB)
03/30/20228:02AMEdgar (US Regulatory)Annual Report (10-k)USOTC:INTIInhibitor Therapeutics Inc (QB)
11/12/20218:02AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:INTIInhibitor Therapeutics Inc (QB)
05/14/20218:02AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:INTIInhibitor Therapeutics Inc (QB)
03/26/20218:03AMEdgar (US Regulatory)Annual Report (10-k)USOTC:INTIInhibitor Therapeutics Inc (QB)
01/19/202112:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:INTIInhibitor Therapeutics Inc (QB)
01/06/20213:31PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:INTIInhibitor Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:INTI

Your Recent History

USOTC
PHIL
PHI (PK)
NASDAQ
DJT
Trump Media and Technology
NASDAQ
COOP
Mr Cooper
USOTC
RDGL
Vivos (QB)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
NSAV
Net Savings Link (PK)
USOTC
RNVA
Rennova Health (PK)
NASDAQ
LWLG
Lightwave Logic
NASDAQ
AMRN
Amarin
NYSE
AMC
AMC Entertainment
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
TPTW
TPT Global Tech (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
BIEL
Bioelectronics (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved